Mustang Bio, Inc. (MBIO)
NASDAQ: MBIO · Real-Time Price · USD
0.4214
-0.0430 (-9.26%)
At close: Nov 13, 2026, 4:00 PM EST
0.4249
+0.0035 (0.83%)
After-hours: Nov 13, 2026, 4:10 PM EST
Mustang Bio Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 14.28 | 17.27 | 6.84 | 6.23 | 75.66 | 109.62 |
Cash & Short-Term Investments | 14.28 | 17.27 | 6.84 | 6.23 | 75.66 | 109.62 |
Cash Growth | -24.80% | 152.46% | 9.71% | -91.76% | -30.98% | 12.08% |
Other Receivables | 0.22 | 0.22 | 0.4 | 3.88 | 0.3 | 0.05 |
Receivables | 0.22 | 0.22 | 0.4 | 3.88 | 0.3 | 0.05 |
Prepaid Expenses | 0.19 | 0.11 | 0.2 | 1.23 | 2.9 | 2.04 |
Other Current Assets | - | - | 1.17 | - | - | - |
Total Current Assets | 14.68 | 17.59 | 8.61 | 11.35 | 78.85 | 111.71 |
Property, Plant & Equipment | - | - | 0.45 | 4.81 | 12.31 | 12.1 |
Other Long-Term Assets | - | - | 0.25 | 1.58 | 1.26 | 1.36 |
Total Assets | 14.68 | 17.59 | 9.31 | 17.74 | 92.42 | 125.17 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 5.42 | 3.51 | 7.46 | 6.32 | 6.83 | 3.51 |
Accrued Expenses | - | 2.78 | 3.09 | 7.79 | 7.02 | 6.4 |
Current Portion of Leases | - | - | 0.46 | 0.52 | 0.61 | 0.35 |
Other Current Liabilities | 2.53 | 1.63 | 1.6 | 0.74 | 0.65 | 0.55 |
Total Current Liabilities | 7.95 | 7.91 | 12.61 | 15.37 | 15.11 | 10.82 |
Long-Term Debt | - | - | - | - | 27.44 | - |
Long-Term Leases | - | - | 0.42 | 1.98 | 3.33 | 1.69 |
Long-Term Unearned Revenue | 0.15 | 0.15 | 0.15 | 0.27 | 0.27 | 0.27 |
Total Liabilities | 8.1 | 8.06 | 13.18 | 17.62 | 46.15 | 12.77 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 0 | 0 | 0.01 | 0 | 0.01 | 0.01 |
Additional Paid-In Capital | 408.22 | 407.9 | 392.23 | 380.5 | 374.52 | 359.91 |
Retained Earnings | -401.64 | -398.64 | -396.72 | -380.97 | -329.37 | -251.84 |
Comprehensive Income & Other | - | 0.27 | 0.61 | 0.59 | 1.11 | 4.33 |
Shareholders' Equity | 6.59 | 9.53 | -3.87 | 0.12 | 46.27 | 112.4 |
Total Liabilities & Equity | 14.68 | 17.59 | 9.31 | 17.74 | 92.42 | 125.17 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | - | - | 0.88 | 2.5 | 31.38 | 2.03 |
Net Cash (Debt) | 14.28 | 17.27 | 5.96 | 3.74 | 44.27 | 107.59 |
Net Cash Growth | -24.80% | 189.65% | 59.56% | -91.56% | -58.85% | 12.57% |
Net Cash Per Share | 2.14 | 3.52 | 9.78 | 21.72 | 288.07 | 918.12 |
Filing Date Shares Outstanding | 7.58 | 7.58 | 3.3 | 1.03 | 0.99 | 0.98 |
Total Common Shares Outstanding | 7.58 | 7.3 | 1.83 | 1.01 | 0.99 | 0.97 |
Working Capital | 6.74 | 9.68 | -4 | -4.03 | 63.74 | 100.89 |
Book Value Per Share | 0.87 | 1.31 | -2.12 | 0.12 | 46.90 | 115.90 |
Tangible Book Value | 6.59 | 9.53 | -3.87 | 0.12 | 46.27 | 112.4 |
Tangible Book Value Per Share | 0.87 | 1.31 | -2.12 | 0.12 | 46.90 | 115.90 |
Machinery | - | - | - | - | 9.15 | 7.07 |
Construction In Progress | - | - | - | 0.03 | 0.95 | 2.03 |
Leasehold Improvements | - | - | - | 7.69 | 7.69 | 7.69 |